Picton Mahoney Asset Management’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-25,258
Closed -$2.65M 363
2020
Q3
$2.65M Sell
25,258
-4,742
-16% -$491K 0.15% 172
2020
Q2
$3.06M Hold
30,000
0.18% 148
2020
Q1
$3.03M Buy
30,000
+27,630
+1,166% +$2.73M 0.17% 126
2019
Q4
$246K Buy
+2,370
New +$235K 0.02% 230

Other funds holding CELU

Picton Mahoney Asset Management's CELU Position: Q4 2020 in Review

Picton Mahoney Asset Management sold out of Celularity (CELU) in Q4 2020, closing a stake of 25,258 shares — an estimated $2.65M sold.

Picton Mahoney Asset Management first reported a position in CELU in Q4 2019 and held it in 4 quarters. The position peaked at $3.06M in Q2 2020. 64 funds tracked by Wall St. Rank hold CELU as of Q4 2020.

  • Picton Mahoney Asset Management reported no remaining Celularity position as of Q4 2020 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 25,258 Celularity shares in Q4 2020, an estimated $2.65M.
  • Picton Mahoney Asset Management first reported a position in Celularity in Q4 2019 and held it in 4 quarters.
  • Picton Mahoney Asset Management's Celularity position peaked at $3.06M in Q2 2020.
  • 64 funds tracked by Wall St. Rank held Celularity as of Q4 2020.

Based on Picton Mahoney Asset Management's 13F filing for Q4 2020, filed 12 Feb 2021.